-
1
-
-
0345256652
-
Cisplatin: Mode of cytotoxic action and molecular basis of resistance
-
Siddik ZH: Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003; 22: 7265-7279.
-
(2003)
Oncogene
, vol.22
, pp. 7265-7279
-
-
Zh, S.1
-
2
-
-
0032168673
-
Clinical development of platinum complexes in cancer therapy: An historical perspective and an update
-
Lebwohl D, Canetta R: Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 1998; 34: 1522-1534.
-
(1998)
Eur J Cancer
, vol.34
, pp. 1522-1534
-
-
Lebwohl, D.1
Canetta, R.2
-
3
-
-
0022879127
-
Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity
-
Ries F, Klastersky J: Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis 1986; 8: 368-379.
-
(1986)
Am J Kidney Dis
, vol.8
, pp. 368-379
-
-
Ries, F.1
Klastersky, J.2
-
4
-
-
3042723541
-
Nephrotoxicity of platinum complexes is related to basolateral organic cation transport
-
Ludwig T, Riethmuller C, Gekle M, Schwerdt G, Oberleithner H: Nephrotoxicity of platinum complexes is related to basolateral organic cation transport. Kidney Int 2004; 66: 196-202.
-
(2004)
Kidney Int
, vol.66
, pp. 196-202
-
-
Ludwig, T.1
Riethmuller, C.2
Gekle, M.3
Schwerdt, G.4
Oberleithner, H.5
-
5
-
-
0018568039
-
Mechanism of action of cis-dichlorodiammineplatinum(II)
-
Zwelling LA, Kohn KW: Mechanism of action of cis- dichlorodiammineplatinum(II). Cancer Treat Rep 1979; 63: 1439-1444.
-
(1979)
Cancer Treat Rep
, vol.63
, pp. 1439-1444
-
-
Zwelling, L.A.1
Kohn, K.W.2
-
6
-
-
0034779861
-
Assessment of cisplatin-induced nephrotoxicity by microarray technology
-
Huang Q, Dunn RT 2nd, Jayadev S, DiSorbo O, Pack FD, Farr SB, Stoll RE, Blanchard KT: Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol Sci 2001; 63: 196-207.
-
(2001)
Toxicol Sci
, vol.63
, pp. 196-207
-
-
Huang, Q.1
Dunn, I.I.R.T.2
Jayadev, S.3
Disorbo, O.4
Pack, F.D.5
Farr, S.B.6
Stoll, R.E.7
Blanchard, K.T.8
-
7
-
-
0036738517
-
TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
-
Ramesh G, Reeves WB: TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 2002; 110: 835-842.
-
(2002)
J Clin Invest
, vol.110
, pp. 835-842
-
-
Ramesh, G.1
Reeves, W.B.2
-
8
-
-
34347336511
-
Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells
-
Zhang B, Ramesh G, Norbury CC, Reeves WB: Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells. Kidney Int 2007; 72: 37-44.
-
(2007)
Kidney Int
, vol.72
, pp. 37-44
-
-
Zhang, B.1
Ramesh, G.2
Norbury, C.C.3
Reeves, W.B.4
-
9
-
-
0032844716
-
Protection from toxicant- mediated renal injury in the rat with anti-CD54 antibody
-
Kelly KJ, Meehan SM, Colvin RB, Williams WW, Bonventre JV: Protection from toxicant- mediated renal injury in the rat with anti-CD54 antibody. Kidney Int 1999; 56: 922-931.
-
(1999)
Kidney Int
, vol.56
, pp. 922-931
-
-
Kelly, K.J.1
Meehan, S.M.2
Colvin, R.B.3
Williams, W.W.4
Bonventre, J.V.5
-
10
-
-
0022134205
-
Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat
-
Winston JA, Safirstein R: Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat. Am J Physiol 1985; 249:F490-F496.
-
(1985)
Am J Physiol
, vol.249
-
-
Winston, J.A.1
Safirstein, R.2
-
11
-
-
0036406927
-
Microvascular endothelial injury and dysfunction during ischemic acute renal failure
-
Sutton TA, Fisher CJ, Molitoris BA: Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 2002; 62: 1539-1549.
-
(2002)
Kidney Int
, vol.62
, pp. 1539-1549
-
-
Sutton, T.A.1
Fisher, C.J.2
Molitoris, B.A.3
-
12
-
-
55049087497
-
Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice
-
Morigi M, Introna M, Imberti B, Corna D, Abbate M, Rota C, Rottoli D, Benigni A, Perico N, Zoja C, Rambaldi A, Remuzzi A, Remuzzi G: Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 2008; 26: 2075-2082.
-
(2008)
Stem Cells
, vol.26
, pp. 2075-2082
-
-
Morigi, M.1
Introna, M.2
Imberti, B.3
Corna, D.4
Abbate, M.5
Rota, C.6
Rottoli, D.7
Benigni, A.8
Perico, N.9
Zoja, C.10
Rambaldi, A.11
Remuzzi, A.12
Remuzzi, G.13
-
13
-
-
84940136598
-
Functional and histopathological changes in dog kidneys after administration of cisplatin
-
Daugaard G, Abildgaard U, Larsen S, Holstein-Rathlou NH, Amtorp O, Olesen HP, Leyssac PP: Functional and histopathological changes in dog kidneys after administration of cisplatin. Ren Physiol 1987; 10: 54-64.
-
(1987)
Ren Physiol
, vol.10
, pp. 54-64
-
-
Daugaard, G.1
Abildgaard, U.2
Larsen, S.3
Holstein-Rathlou, N.H.4
Amtorp, O.5
Olesen, H.P.6
Leyssac, P.P.7
-
14
-
-
0043172250
-
Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: A randomized trial
-
Santoso JT, Lucci JA 3rd, Coleman RL, Schafer I, Hannigan EV: Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial. Cancer Chemother Pharmacol 2003; 52: 13-18.
-
(2003)
Cancer Chemother Pharmacol
, vol.52
, pp. 13-18
-
-
Santoso, J.T.1
Lucci III, J.A.2
Coleman, R.L.3
Schafer, I.4
Hannigan, E.V.5
-
15
-
-
0017686755
-
The renal pathology in clinical trials of cis-platinum (II) diamminedichloride
-
Gonzales-Vitale JC, Hayes DM, Cvitkovic E, Sternberg SS: The renal pathology in clinical trials of cis-platinum (II) diamminedichloride. Cancer 1977; 39: 1362-1371.
-
(1977)
Cancer
, vol.39
, pp. 1362-1371
-
-
Gonzales-Vitale, J.C.1
Hayes, D.M.2
Cvitkovic, E.3
Sternberg, S.S.4
-
16
-
-
42149187768
-
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
-
Pabla N, Dong Z: Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 2008; 73: 994-1007.
-
(2008)
Kidney Int
, vol.73
, pp. 994-1007
-
-
Pabla, N.1
Dong, Z.2
-
17
-
-
4043163418
-
Neutrophil gelatinase-associated lipocalin: A novel early urinary biomarker for cisplatin nephrotoxicity
-
Mishra J, Mori K, Ma Q, Kelly C, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004; 24: 307-315.
-
(2004)
Am J Nephrol
, vol.24
, pp. 307-315
-
-
Mishra, J.1
Mori, K.2
Ma, Q.3
Kelly, C.4
Barasch, J.5
Devarajan, P.6
-
18
-
-
39449098471
-
Amelioration of cisplatin induced nephrotoxicity in mice by an ethyl acetate extract of Lagerstroemia speciosa (L)
-
Priya TT, Sabu MC, Jolly CI: Amelioration of cisplatin induced nephrotoxicity in mice by an ethyl acetate extract of Lagerstroemia speciosa (L). J Basic Clin Physiol Pharmacol 2007; 18: 289-298.
-
(2007)
J Basic Clin Physiol Pharmacol
, Issue.18
, pp. 289-298
-
-
Priya, T.T.1
Sabu, M.C.2
Jolly, C.I.3
-
20
-
-
0021869646
-
Course of acute renal failure studied by a model of creatinine kinetics
-
Moran SM MB: Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int 1985; 27: 982-1937
-
(1985)
Kidney Int
, vol.27
, pp. 982-1937
-
-
Moran, S.M.M.B.1
-
21
-
-
0031783727
-
Treatment of acute renal failure
-
Star RA: Treatment of acute renal failure. Kidney Int 1998; 54: 1817-1831.
-
(1998)
Kidney Int
, vol.54
, pp. 1817-1831
-
-
Star, R.A.1
-
22
-
-
0242669254
-
Differential gene expression following early renal ischemia/reperfusion
-
Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, Devarajan P: Differential gene expression following early renal ischemia/reperfusion. Kidney Int 2003; 63: 1714-1724.
-
(2003)
Kidney Int
, vol.63
, pp. 1714-1724
-
-
Supavekin, S.1
Zhang, W.2
Kucherlapati, R.3
Kaskel, F.J.4
Moore, L.C.5
Devarajan, P.6
-
23
-
-
0141678253
-
Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury
-
Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003; 14: 2534-2543.
-
(2003)
J Am Soc Nephrol
, vol.14
, pp. 2534-2543
-
-
Mishra, J.1
Ma, Q.2
Prada, A.3
Mitsnefes, M.4
Zahedi, K.5
Yang, J.6
Barasch, J.7
Devarajan, P.8
-
24
-
-
0344924850
-
Gene expression in early ischemic renal injury: Clues towards pathogenesis, biomarker discovery, and novel therapeutics
-
Devarajan P, Mishra J, Supavekin S, Patterson LT, Potter S: Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol Genet Metab 2003; 80: 365-376.
-
(2003)
Mol Genet Metab
, vol.80
, pp. 365-376
-
-
Devarajan, P.1
Mishra, J.2
Supavekin, S.3
Patterson, L.T.4
Potter, S.5
-
25
-
-
20144388328
-
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery
-
Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365: 1231-1238.
-
(2005)
Lancet
, vol.365
, pp. 1231-1238
-
-
Mishra, J.1
Dent, C.2
Tarabishi, R.3
Mitsnefes, M.M.4
Ma, Q.5
Kelly, C.6
Ruff, S.M.7
Zahedi, K.8
Shao, M.9
Bean, J.10
Mori, K.11
Barasch, J.12
Devarajan, P.13
-
26
-
-
0027213497
-
Phase II study of 4'-iodo-4'-deoxydoxorubicin in non-resectable non-small-cell lung cancer
-
Sorensen JB, Stenbygaard L, Drivsholm L, Dombernowsky P, Hansen HH: Phase II study of 4'-iodo-4'-deoxydoxorubicin in non-resectable non-small-cell lung cancer. Cancer Chemother Pharmacol 1993; 32: 399-402.
-
(1993)
Cancer Chemother Pharmacol
, vol.32
, pp. 399-402
-
-
Sorensen, J.B.1
Stenbygaard, L.2
Drivsholm, L.3
Dombernowsky, P.4
Hansen, H.H.5
-
27
-
-
0035106967
-
Estimation of glomerular filtration rate in cancer patients
-
Wright JG, Boddy AV, Highley M, Fenwick J, McGill A, Calvert AH: Estimation of glomerular filtration rate in cancer patients. Br J Cancer 2001; 84: 452-459.
-
(2001)
Br J Cancer
, vol.84
, pp. 452-459
-
-
Wright, J.G.1
Boddy, A.V.2
Highley, M.3
Fenwick, J.4
McGill, A.5
Calvert, A.H.6
-
28
-
-
73949148024
-
The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury
-
Haase-Fielitz A, Bellomo R, Devarajan P, Bennett M, Story D, Matalanis G, Frei U, Dragun D, Haase M: The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dial Transplant 2009; 24: 3349-3354.
-
(2009)
Nephrol Dial Transplant
, vol.24
, pp. 3349-3354
-
-
Haase-Fielitz, A.1
Bellomo, R.2
Devarajan, P.3
Bennett, M.4
Story, D.5
Matalanis, G.6
Frei, U.7
Dragun, D.8
Haase, M.9
-
29
-
-
36749087090
-
Clinical research of kidney diseases III: Principles of regression and modelling
-
DOI 10.1093/ndt/gfm777
-
Ravani P, Parfrey P, Gadag V, Malberti F, Barrett B: Clinical research of kidney diseases III: principles of regression and modelling. Nephrol Dial Transplant 2007; 22: 3422-3430. (Pubitemid 350212529)
-
(2007)
Nephrology Dialysis Transplantation
, vol.22
, Issue.12
, pp. 3422-3430
-
-
Ravani, P.1
Parfrey, P.2
Gadag, V.3
Malberti, F.4
Barrett, B.5
-
30
-
-
0027161110
-
Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin
-
Cornelison TL, Reed E: Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin. Gynecol Oncol 1993; 50: 147-158.
-
(1993)
Gynecol Oncol
, vol.50
, pp. 147-158
-
-
Cornelison, T.L.1
Reed, E.2
-
31
-
-
0019517501
-
High-dose cisplatin therapy using mannitol versus furosemide diuresis: Comparative pharmacokinetics and toxicity
-
Ostrow S, Egorin MJ, Hahn D, Markus S, Aisner J, Chang P, LeRoy A, Bachur NR, Wiernik PH: High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicity. Cancer Treat Rep 1981; 65: 73-78.
-
(1981)
Cancer Treat Rep
, vol.65
, pp. 73-78
-
-
Ostrow, S.1
Egorin, M.J.2
Hahn, D.3
Markus, S.4
Aisner, J.5
Chang, P.6
Leroy, A.7
Bachur, N.R.8
Wiernik, P.H.9
-
32
-
-
67649234742
-
Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass
-
Tuladhar SM, Puntmann VO, Soni M, Punjabi PP, Bogle RG: Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass. J Cardiovasc Pharmacol 2009; 53: 261-266.
-
(2009)
J Cardiovasc Pharmacol
, vol.53
, pp. 261-266
-
-
Tuladhar, S.M.1
Puntmann, V.O.2
Soni, M.3
Punjabi, P.P.4
Bogle, R.G.5
-
33
-
-
63249099066
-
Circulating neutrophil gelatinase-associated lipocalin: A useful biomarker for assessing disease activity of ANCA-associated vasculitis
-
Chen M, Wang F, Zhao MH: Circulating neutrophil gelatinase-associated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis. Rheumatology (Oxford) 2009; 48: 355-358.
-
(2009)
Rheumatology (Oxford)
, vol.48
, pp. 355-358
-
-
Chen, M.1
Wang, F.2
Zhao, M.H.3
-
34
-
-
44649171719
-
Urine NGAL predicts severity of acute kidney injury after cardiac surgery: A prospective study
-
Bennett M, Dent CL, Ma Q, Dastrala S, Grenier F, Workman R, Syed H, Ali S, Barasch J, Devarajan P: Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 2008; 3: 665-673.
-
(2008)
Clin J Am Soc Nephrol
, vol.3
, pp. 665-673
-
-
Bennett, M.1
Dent, C.L.2
Ma, Q.3
Dastrala, S.4
Grenier, F.5
Workman, R.6
Syed, H.7
Ali, S.8
Barasch, J.9
Devarajan, P.10
-
35
-
-
9644307879
-
Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin
-
Mishra J, Mori K, Ma Q, Kelly C, Yang J, Mitsnefes M, Barasch J, Devarajan P: Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2004; 15: 3073-3082.
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 3073-3082
-
-
Mishra, J.1
Mori, K.2
Ma, Q.3
Kelly, C.4
Yang, J.5
Mitsnefes, M.6
Barasch, J.7
Devarajan, P.8
-
36
-
-
0030783771
-
Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: Incidence and implications for hematologic recovery and clinical outcome
-
Beyer J, Rick O, Weinknecht S, Kingreen D, Lenz K, Siegert W: Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome. Bone Marrow Transplant 1997; 20: 813-819.
-
(1997)
Bone Marrow Transplant
, vol.20
, pp. 813-819
-
-
Beyer, J.1
Rick, O.2
Weinknecht, S.3
Kingreen, D.4
Lenz, K.5
Siegert, W.6
|